among of the best-characterized immune system cells. 1 They develop in the thymus and acquire the potential to differentiate into distinct subpopulations. Upon leaving the thymus, T helper cells further differentiate in the periphery in response to signals from T-cell receptors, cytokines and other ligands in the microenvironment. CD4 + T cells have high plasticity and can differentiate into several different subtypes. This subdivision is based on the expression of lineagespecific transcription factors, which function as 'mater regulators' for specific T H subsets.
T H 1 differentiation is driven by IL-12, which promotes the expression of IFNγ and transcription factor T-BET (encoded by T-box 21). T H 2 cells express the master regulator GATA-binding protein 3 (GATA3) when induced by IL-4 and secrete IL-4, IL-5 and IL-13. Transforming growth factor β (TGFβ), in combination with IL-4, induces differentiation to T H 9 cells, which produce IL-9 and IL-10. PU.1 has been suggested as a master transcription factor. T follicular helper (T fH ) cells are induced by IL-6 and IL-21 and express master regulator BCL6. In addition, TGFβ and IL-23 in combination with IL-6 or IL-21 promote T H 17 development. These cells produce IL-17, IL-21 and IL-22 and express the lineage-specific transcription factor RORγt. Regulatory T cells (nTreg) can develop directly in the thymus; they express FOXP3 and inhibit T effector cell functions. Tr1 cells are poorly defined regulatory T cells; 2 they are FOXP3 negative and express high levels of anti-inflammatory cytokines like IL-10.
The diversity of the differentiation possibilities of CD4 + T cells raises the question as to the degree to which a single master regulator contributes to the differentiation, especially because in some cells similar factors are expressed. Gene expression analysis is typically carried out by analyzing induced genes but does not explain why expression of the same transcription factor in the same cell types leads to different gene subsets. The combination of gene expression and chromatin accessibility analysis allows analysis of another level of gene regulation. Pioneering factors that alter chromatin also affect the accessibility of transcription factors to specific genes. For the differentiation of T H 17 cells, the cooperative binding of BATF and interferon regulatory factors (IRF4) enables chromatin accessibility and the subsequent recruitment of RORγt to regulate selected sets of T H 17-relevant genes [3] [4] [5] (Figure 1) .
In a recent issue of Nature Immunology, Karwacz et al. 6 exploited the role of IRF1 and BATF as pioneering factors for CD4 + T-cell differentiation to Tr1 cells. The investigators analyzed global gene expression following engagement of TCRs on naive CD4 + T cells cultured under Tr1 polarizing conditions. Irf1 and Batf mRNA showed a dual wave expression profile with an early peak between 1 and 6 h after activation. Moreover, stimulation of naive CD4 + T cells from knockout failed to produce Il10 mRNA or differentiation into Tr1 cells.
IL-27 receptor signaling is known to induce Tr1 cell differentiation. Furthermore, both STAT1 and STAT3 are required for Tr1 differentiation. Karwacz and colleagues showed that STAT1 signaling was responsible for Irf1 induction, whereas STAT3 was essential for BATF, indicating a distinct regulation of both transcription factors. The authors also investigated whether both transcription factors cooperate in Tr1-specific gene expression, whereas IRF1 expression leads to high induction of IL-10. Batf overexpression strongly induced Maf and Il12, whereas Ahr expression was induced by both. These results suggest that both transcription factors cooperate in gene induction and induce a distinct set of genes.
To assess the role of IRF1 in autoimmune disease, Karwacz and coauthors used an experimental autoimmune encephalomyelitis (EAE) model. In previous studies, C57/BL6J Irf1-deficient mice were found to be resistant to EAE upon immunization with MOG 35-55 when compared with wild-type mice. 7, 8 This phenotypic characterization was associated with impaired Th1 cell differentiation and biased development toward Th2 cell phenotype. Thus, Karwacz showed that loss of IRF1 led to an increased clinical core upon EAE induction and increased numbers of IL-17-and IFNγ-expressing T cells in the central nervous system of Irf1 −/− mice. More importantly, the transfer of Irf1 −/− T cells into Rag2 −/− mice and induction of EAE resulted in increased disease scores; higher numbers of IL-17 producing cells were isolated. These data provide evidence that IRF1 inhibited Th17 cell differentiation in vivo. Furthermore, Irf1-and Batf-deficient mice were not able to generate functional Tr1 cells, whereas the adaptive transfer of wt Tr1 cells inhibits disease and the transfer of Irf1-deficient Tr1 cells exacerbated disease. Thus, IRF1 and BATF control the in vivo generation of Tr1 cells. To investigate whether BATF or IRF1 could affect epigenetic markers, ChIPqPCR assays on the IL-10 locus were performed in Tr1 polarized knockout cells. Irf1 and Batf deficiency resulted in decreased recruitment of activating factors and increased repressive factors. Thus, both transcription factors seem to induce epigenetic changes during Tr1 cell differentiation. Reporter assays using promoter elements with high BATF and IRF1 co-occupancy showed that only IRF1 was able to directly induce the IL-10 promoter. Moreover, both factors provide binding sites for other transcription factors, suggesting that both factors could induce chromatin changes, which allow the exclusive or cooperative binding of other transcription factors.
Karwacz and colleagues used intensive ATAC-seq analyses of Tr1 polarized knockout cells to assess the potential pioneering roles of BATF and IRF1 during Tr1 differentiation. They detected 180 000 accessible regions across the samples. In contrast to Irf1, c-Maf and AhR, Batf −/− T H 0 and Tr1 cells had distinct chromatin accessibility patterns, providing high-level support for BATF as a pioneering factor in Tr1 cells. DESeq2 analysis was used to quantify the number of transcription-factor-dependent accessible peaks per transcription factor in Tr1 conditions. BATF deficiency led to altered accessibility at over 20 000 loci, IRF1 deficiency of 1200 loci and only minor alterations in Ahr and c-Mafs cells. Although the scale of IRF1-and BATFdependent changes differs, both transcription factors altered chromatin accessibility, whereas c-MAF and AhR did not. Thus, both IRF1 and BATF are necessary for additional Tr1 transcription factors to bind chromatin and support the role for IRF1 and BATF as pioneering factors. Taking the findings together this study uncovered the critical role of IRF1 and BATF in preparing the chromatin landscape for the induction of the Tr1 gene network in response to IL-27 signaling. Where BATF acts as a pioneer factor and prepares the genomic landscape for the binding of additional transcription factors that define the Tr1 lineage, IRF1 specifically transactivates IL-10 gene expression and a smaller cluster of genes that characterize the Tr1 lineage while retaining T H 17 differentiation. These data indicate that BATF and IRF-1 are drivers of the earliest steps in the induction of Tr1 lineage (Figure 1 ).
